Medscape (11/16, Nelson) reports that the Food and Drug Administration approved for long-term use the SAVI Scout reflector, a wire-free, nonradioactive breast tumor localization device that is part of the SAVI Scout surgical guidance system made by Cianna Medical Inc. Medscape says, “The system uses an intratumoral electromagnetic wave device, implanted under ultrasound or mammographic guidance, to localize occult breast lesions with a probe during surgery.” The approval is important because “with the new FDA clearance, it can remain in place during the period between biopsy and surgery,” reducing the need for reexcision.
Aunt Minnie (11/10) reported that bipartisan legislation “that would standardize communication to women regarding whether they have dense breast tissue on mammography” has been “introduced in both the US House” and Senate. Among other things, the legislation “would set a minimum federal standard, as designated by the US Secretary of Health and Human Services (HHS), for notification about dense tissue and recommend that women discuss with their healthcare providers whether they would benefit from additional screening.”
Aunt Minnie (11/9) reports that “the American College of Radiology’s (ACR) expert panel on breast imaging has published appropriateness criteria for breast cancer screening.” The criteria were published in the Journal of the American College of Radiology.
The Radiology Business Journal (11/8, Walter) provides coverage of a new analysis exploring both the benefits and risks of undergoing screening mammography when women turn 75. According to the article, the authors of the analysis conclude that “women should not stop undergoing regular mammography based on their age alone.” They wrote, “Older women are a vulnerable population at risk of developing and dying from breast cancer; however, screening mammography remains underutilized in these women.” One author pointed out “that imaging societies have varying opinions on this issue.” For example, both the Society of Breast Imaging and the American College of Radiology do “not recommend stopping screening on the basis of age.” The findings were published in the American Journal of Roentgenology
HealthDay (11/6, Preidt) reports that a survey suggests “many breast cancer patients skip recommended treatment after surgery because they lack faith in the health care system.” The “survey found those who reported a general distrust of medical institutions and insurers were more likely to forgo follow-up breast cancer treatment, such as chemotherapy, hormone therapy or radiation.” Meanwhile, “trust or distrust of their own doctors did not emerge as a factor.” The findings were published in Cancer Epidemiology, Biomarkers & Prevention.